Reports
Sale
Global Venous Stents Market Size, Share, Trends, Growth: By Technology: Iliac Vein Stent Technology, Wallstent Technology, Others; By Indication: Chronic Deep Vein Thrombosis, Post-Thrombotic Syndrome, May-Thurner’s Syndrome, Others; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Venous Stents Market Size
The global venous stents market was valued at USD 1.10 billion in 2023, driven by increasing incidence of venous diseases across the globe. The market is expected to grow at a CAGR of 8.45% during the forecast period of 2024-2032, with the values likely to reach USD 2.29 billion by 2032.
Global Venous Stents Market Outlook
- The demand for venous stents is on the rise driven by increasing preference for non-invasive procedures.
- One of the major market trends includes the adoption of advanced technologies to improve procedure success rates and patient outcomes.
- North America region is expected to experience notable growth in the forecast period. Advanced healthcare infrastructure and increased public awareness is projected to boost the market value.
Global Venous Stents Market Overview
Venous stents are metal mesh-like tubes that expand against narrowed or blocked vein walls in order to maintain the blood flow. These stents are used in the treatment of conditions like chronic venous insufficiency (CVI) and deep vein thrombosis (DVT) to ensure proper blood flow through the affected vein. The market is driven by increasing advancements in venous stent design, rising healthcare expenditure and initiatives to boost awareness around early detection of diseases across the globe.
Global Venous Stents Market Growth Drivers
Increasing Prevalence of Venous Diseases to Affect the Market Landscape Significantly
The increase in prevalence of venous diseases like deep vein thrombosis, venous thromboembolism, and May-Thurner syndrome among others which can be attributed to lifestyle changes and increasing obesity cases in the population is driving growth for venous stents. The economic burden of the disease is also significant due to the cost of medical care.
Adoption of Wallstent Technology to Meet Rising Venous Stents Market Demand
With a rising need to combat venous diseases, the market is witnessing several innovations in products and technology to offer improved solutions to patients. Self-expending stents are taking over the market with the products like Vici, Venovo Venous Stent System, and Abre Venous Self-Expanding Stent System launched by the major market players. Wallstent technology offers multiple advantages such as reduction in complications, improved central venous luminal diameter and provides treatment of symptomatic venous outflow obstruction. Venous Wallstent provides compression resistance as well as fracture resistance. The integration of such technologies is expected to drive market growth and provide a better quality of life to patients.
Global Venous Stents Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
| Trends | Impact |
| Increasing Obesity Rates | Obesity is a major risk for venous diseases, as the body weight can pressurize veins, leading to damage to valves. Along with these, sedentary lifestyle and diabetes can exacerbate the risk of DVT in individuals. In addition, older people are more susceptible to venous conditions due to reduced mobility. |
| Advancements in Technology | Development of advanced venous stents provides superior performance. They are made more flexible without compromising strength. Incorporation of new materials and coatings are being developed taken into consideration the biocompatibility. To prevent restenosis, drug eluting stents are being developed which locally release drug over a period of time. Bioresorbable stents, intended to be dissolved in the body are also emerging. |
| Increasing Demand for Minimally Invasive Procedures | There is a shift from traditional open surgeries to minimally invasive surgeries. The shift can be accredited to several benefits such has smaller incisions and faster recovery time. Minimally invasive surgeries also provide reduced risk of complications and pain. Advancements in surgical tools and imaging technology improves efficacy and safety. |
| Increased Public Awareness | Education campaigns by healthcare personnel and manufacturers targets to educate the public regarding the symptoms and risks associated with venous diseases. Spreading awareness to emphasize the importance and benefit of recognizing signs and early diagnosis to prevent worsening of conditions, along with information around minimally invasive procedures is another market trend. |
Global Venous Stents Market Segmentation
Market Breakup by Technology
- Iliac Vein Stent Technology
- Wallstent Technology
- Others
Market Breakup by Indication
- Chronic Deep Vein Thrombosis
- Post Thrombotic Syndrome
- May-Thurner Syndrome
- Pelvic Congestion Syndrome (PCS)
- Others
Market Breakup by Application
- Leg
- Chest
- Abdomen
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgery Centers
- Specialty Clinics
- Cardiac Catheterization Labs
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Venous Stents Market Share
Wallstent Technologies Expected to Lead the Market Share Based on Technology
Based on technology, the market segmentation includes iliac vein stent technology, wallstent technology, and others. Wallstent technology is popular for its high adaptability as well as structural flexibility to venous anatomy and holds a notable market share. Iliac vein stent technology is experiencing rapid growth. The growth is propelled by its vital role in treatment of iliac vein obstruction. It is further fueled by advancements in imaging technologies and procedural techniques which enhances safety and precision of stent placements.
Market Segmentation Based on Disease Areas is Anticipated to Witness Substantial Growth
Based on disease, the market constitutes acute deep vein thrombosis (DVT), chronic DVT/ post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesions (NIVL)/May-Thurner Syndrome (MTS) among others. Out of these, acute DVT is estimated to hold a significant market share. NIVL/MTS is also projected to witness substantial growth, owing to advancements in diagnostic technology which are enhancing the specificity of treatment for the condition. As awareness regarding this conditions rise, the demand for specialized stents is also expected to increase.
Global Venous Stents Market Analysis by Region
On the basis of region, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America boasts an advanced healthcare infrastructure along with presence of key healthcare companies. As a result, it leads the market share. In addition, investments in research and development and medical devices are boosting this region’s market growth. Europe follows closely, with growth driven by governmental support for healthcare innovations and growing prevalence of venous conditions. Focus on improving healthcare outcomes and adoption of new technologies are the major factors for the market’s expansion.
Leading Players in the Global Venous Stents Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Becton, Dickinson and Company
- Bentley
- Boston Scientific Corporation
- Cardinal Health
- Cook Group Incorporated
- Koninklijke Philips N.V.
- Medtronic
- W.L Gore & Associates, Inc.
- Shanghai MicroPort Endovascular MedTech (Group)Co., Ltd.
- Jotec GmbH
- Optimed Medizinische Instrumente GmbH
- MicroPort Scientific Corporation
- Medica Germany GMBH & Co.KG
- Cordis Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Indication |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Questions Answered in the Global Venous Stents Market Report
- What was the global venous stents market value in 2023?
- What is the global venous stents market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on indication?
- Who are the major end users in the market?
- What type of technologies are present in the market?
- Where does venous stents find its application?
- What are the major factors aiding the global venous stents market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major market trends influencing the market?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How does the prevalence and incidence of cardiovascular diseases affect the market landscape?
- How does the rise in the geriatric population impact the market size?
- What disease will dominate the market share?
- Which application area is expected to have a high market value in the forecast period?
- Which technology type will experience the highest demand in the market segment?
- Who are the key players involved in the venous stents market?
- What is patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Venous Stents Market Overview
3.1 Global Venous Stents Market Historical Value (2017-2023)
3.2 Global Venous Stents Market Forecast Value (2024-2032)
4 Global Venous Stents Market Landscape*
4.1 Global Venous Stents Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Venous Stents Market: Product Landscape
4.2.1 Analysis by Detection Target
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Venous Stents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Venous Stents Market Segmentation (2017-2032)
6.1 Global Venous Stents Market (2017-2032) by Technology
6.1.1 Market Overview
6.1.2 Iliac Vein Stent Technology
6.1.3 Wallstent Technology
6.1.4 Others
6.2 Global Venous Stents Market (2017-2032) by Indication
6.2.1 Market Overview
6.2.2 Chronic Deep Vein Thrombosis
6.2.3 Post-Thrombotic Syndrome (PTS)
6.2.4 May-Thurner’s Syndrome
6.2.5 Pelvic Congestion Syndrome (PCS)
6.2.6 Others
6.3 Global Venous Stents Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Leg
6.3.3 Chest
6.3.4 Abdomen
6.3.5 Others
6.4 Global Venous Stents Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgery Centers
6.4.4 Specialty Clinics
6.4.5 Cardiac Catheterization Labs
6.4.6 Others
6.5 Global Venous Stents Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Venous Stents Market (2017-2032)
7.1 North America Venous Stents Market (2017-2032) by Technology
7.1.1 Market Overview
7.1.2 Iliac Vein Stent Technology
7.1.3 Wallstent Technology
7.1.4 Others
7.2 North America Venous Stents Market (2017-2032) by Indication
7.2.1 Market Overview
7.2.2 Chronic Deep Vein Thrombosis
7.2.3 Post-Thrombotic Syndrome (PTS)
7.2.4 May-Thurner’s Syndrome
7.2.5 Pelvic Congestion Syndrome (PCS)
7.2.6 Others
7.3 North America Venous Stents Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Venous Stents Market (2017-2032)
8.1 Europe Venous Stents Market (2017-2032) by Technology
8.1.1 Market Overview
8.1.2 Iliac Vein Stent Technology
8.1.3 Wallstent Technology
8.1.4 Others
8.2 Europe Venous Stents Market (2017-2032) by Indication
8.2.1 Market Overview
8.2.2 Chronic Deep Vein Thrombosis
8.2.3 Post-Thrombotic Syndrome (PTS)
8.2.4 May-Thurner’s Syndrome
8.2.5 Pelvic Congestion Syndrome (PCS)
8.2.6 Others
8.3 Europe Venous Stents Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Venous Stents Market (2017-2032)
9.1 Asia Pacific Venous Stents Market (2017-2032) by Technology
9.1.1 Market Overview
9.1.2 Iliac Vein Stent Technology
9.1.3 Wallstent Technology
9.1.4 Others
9.2 Asia Pacific Venous Stents Market (2017-2032) by Indication
9.2.1 Market Overview
9.2.2 Chronic Deep Vein Thrombosis
9.2.3 Post-Thrombotic Syndrome (PTS)
9.2.4 May-Thurner’s Syndrome
9.2.5 Pelvic Congestion Syndrome (PCS)
9.2.6 Others
9.3 Asia Pacific Venous Stents Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Venous Stents Market (2017-2032)
10.1 Latin America Venous Stents Market (2017-2032) by Technology
10.1.1 Market Overview
10.1.2 Iliac Vein Stent Technology
10.1.3 Wallstent Technology
10.1.4 Others
10.2 Latin America Venous Stents Market (2017-2032) by Indication
10.2.1 Market Overview
10.2.2 Chronic Deep Vein Thrombosis
10.2.3 Post-Thrombotic Syndrome (PTS)
10.2.4 May-Thurner’s Syndrome
10.2.5 Pelvic Congestion Syndrome (PCS)
10.2.6 Others
10.3 Latin America Venous Stents Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Venous Stents Market (2017-2032)
11.1 Middle East and Africa Venous Stents Market (2017-2032) by Technology
11.1.1 Market Overview
11.1.2 Iliac Vein Stent Technology
11.1.3 Wallstent Technology
11.1.4 Others
11.2 Middle East and Africa Venous Stents Market (2017-2032) by Indication
11.2.1 Market Overview
11.2.2 Chronic Deep Vein Thrombosis
11.2.3 Post-Thrombotic Syndrome (PTS)
11.2.4 May-Thurner’s Syndrome
11.2.5 Pelvic Congestion Syndrome (PCS)
11.2.6 Others
11.3 Middle East and Africa Venous Stents Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Component of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Product
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Component of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Component of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Companies
17.2 Abbott Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Becton, Dickinson and Company
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Bentley
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Boston Scientific Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cardinal Health
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Cook Group Incorporated
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Koninklijke Philips N.V.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Medtronic
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 W.L Gore & Associates, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Shanghai MicroPort Endovascular MedTech (Group)Co., Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Jotec GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Optimed Medizinische Instrumente GmbH
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 MicroPort Scientific Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Medica Germany GMBH & Co.KG
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Cordis Inc.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Venous Stents Market– Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER